1901 Avenue of the Stars,
Los Angeles, CA, 90067, United States
Vitality Biopharma Inc is engaged in the development of cannabinoid prodrug pharmaceuticals. Vitality Biopharma has developed a new class of cannabinoid prodrugs, known as cannabosides, which upon ingestion can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. It develops cannabinoid product named VITA-100. VITA-100 is an oral cannabinoid formulation containing cannabosides that is being developed for the acute treatment of inflammatory bowel disease and narcotic bowel syndrome.